251 related articles for article (PubMed ID: 11147563)
1. Pharmacokinetic properties of current antiepileptic drugs: what improvements are needed?
Bourgeois BF
Neurology; 2000; 55(11 Suppl 3):S11-6. PubMed ID: 11147563
[TBL] [Abstract][Full Text] [Related]
2. Important pharmacokinetic properties of antiepileptic drugs.
Bourgeois BF
Epilepsia; 1995; 36 Suppl 5():S1-7. PubMed ID: 8806398
[TBL] [Abstract][Full Text] [Related]
3. Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies.
Patsalos PN
Epilepsia; 2005; 46 Suppl 9():140-8. PubMed ID: 16302888
[TBL] [Abstract][Full Text] [Related]
4. Some common issues in the use of antiepileptic drugs.
Asconapé JJ
Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
Johannessen SI; Tomson T
Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
[TBL] [Abstract][Full Text] [Related]
6. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
7. Drug interactions between chemotherapeutic regimens and antiepileptics.
Yap KY; Chui WK; Chan A
Clin Ther; 2008 Aug; 30(8):1385-407. PubMed ID: 18803983
[TBL] [Abstract][Full Text] [Related]
8. New antiepileptic drugs: review on drug interactions.
Hachad H; Ragueneau-Majlessi I; Levy RH
Ther Drug Monit; 2002 Feb; 24(1):91-103. PubMed ID: 11805729
[TBL] [Abstract][Full Text] [Related]
9. [Current pharmacotherapy of epilepsy in adults].
Beyenburg S
Bull Soc Sci Med Grand Duche Luxemb; 2005; (3):263-81. PubMed ID: 17176542
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and interactions of antiepileptic drugs.
Graves NM
Am J Hosp Pharm; 1993 Dec; 50(12 Suppl 5):S23-9; quiz S30-2. PubMed ID: 8122698
[TBL] [Abstract][Full Text] [Related]
11. [Which drugs should be chosen for the different types of epilepsy?].
Armijo JA
Rev Neurol; 1997 Mar; 25(139):356-66. PubMed ID: 9147776
[TBL] [Abstract][Full Text] [Related]
12. Clinically relevant drug interactions with antiepileptic drugs.
Perucca E
Br J Clin Pharmacol; 2006 Mar; 61(3):246-55. PubMed ID: 16487217
[TBL] [Abstract][Full Text] [Related]
13. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptic drug interactions.
Díaz RA; Sancho J; Serratosa J
Neurologist; 2008 Nov; 14(6 Suppl 1):S55-65. PubMed ID: 19225371
[TBL] [Abstract][Full Text] [Related]
15. Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs.
Reife RA
Adv Neurol; 1998; 76():95-103. PubMed ID: 9408466
[TBL] [Abstract][Full Text] [Related]
16. Antiepileptic drugs: indications other than epilepsy.
Spina E; Perugi G
Epileptic Disord; 2004 Jun; 6(2):57-75. PubMed ID: 15246950
[TBL] [Abstract][Full Text] [Related]
17. Chemical properties of antiepileptic drugs (AEDs).
Bialer M
Adv Drug Deliv Rev; 2012 Jul; 64(10):887-95. PubMed ID: 22210279
[TBL] [Abstract][Full Text] [Related]
18. Targets for antiepileptic drugs in the synapse.
Landmark CJ
Med Sci Monit; 2007 Jan; 13(1):RA1-7. PubMed ID: 17179916
[TBL] [Abstract][Full Text] [Related]
19. New antiepileptic agents.
Nelson LP; Savelli-Castillo I
Pediatr Dent; 2004; 26(1):58-62. PubMed ID: 15080360
[TBL] [Abstract][Full Text] [Related]
20. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs.
Patsalos PN; Perucca E
Lancet Neurol; 2003 Jun; 2(6):347-56. PubMed ID: 12849151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
